- Global oncology trends
- EU market access: Past and future
- The future of medical health apps
- Launching biosimilars in Europe
New biosimilar switching regulations prioritise cost-effective options and discount agreements, imp...Read more
Proposed changes in Germany's pharma strategy suggest replacing publicly listed AMNOG rebates with c...Read more
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.